Hematology Analyzers and Reagents Market worth $3.13 Billion by 2019

The report “Hematology Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019”, This report studies the global hematology instruments and reagents market over the forecast period of 2014 to 2019. The market is expected to reach $3.13 billion by 2019, at CAGR of 5.2% from 2014 to 2019.

Browse more than 79 market data tables with 33 figures spread through 282 pages and in-depth TOC on "Hematology Reagents Market"
Early buyers will receive 10% customization on this report.

The global hematology market is divided into hematology products& services. Hematology products market has been segmented into instruments and consumables. The hematology instruments market is further segmented into analyzers and slide strainers/makers. Whereas, the hematology consumables market has been classified into three major segments namely; regents, stains, and controls and calibrators. Furthermore, based on the end-users, the global hematology market has been segmented into commercial organizations, stand-alone hospitals, research institutes, and clinical testing labs.

Get The Sample Copy@

A number of factors such as development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, increasing adoption of automated hematology instruments by diagnostics laboratories, technological advancements, and developments in high sensitivity point-of-care (POC) hematology testing are propelling the growth of the global hematology analyzers and reagents market. On the other hand, slow adoption of the advanced hematology instruments in the emerging economies, hematology product recalls, and high cost of hematology analyzers are restricting the growth of the global market.

As of 2014, North America holds the largest share of the global market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR of ~9.4% from 2014 to 2019. A number of factors including developing healthcare infrastructure, large patient population, increasing funding/investment toward the development of hematology products, and growing focus of both international and domestic players on the Asia-Pacific countries are stimulating the growth of the market in the Asia-Pacific region.

Speak to Research Analyst:

Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), HORIBA, Ltd. (Japan), Siemens AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Boule Diagnostics AB (Sweden), Mindray Medical International Limited (China), Nihon Kohden Corporation (Japan), and Roche Diagnostics (Switzerland) are the key players operating in the global market.

Browse related reports:
Point-Of-Care Diagnostics Market
by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018.

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017.

About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Mr. Rohan

North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Visit MarketsandMarkets Blog@
Connect with us on LinkedIn @